Health Canada is recommending against administering the Oxford-AstraZeneca vaccine to people under 55 following new reports of patients developing blood clots in Europe.
CANADA - Health Canada is recommending the provinces and territories suspend use of the Oxford-AstraZeneca COVID-19 vaccine for people under the age of 55.
This is following new reports of patients in Europe developing blood clots. Most of them were women under 55 and the fatality rate is as high as 40 percent.
Health Canada would like the drugmaker to conduct a detailed study on the risks and benefits of the vaccine across multiple age groups.
The National Committee on Immunizations is also recommending against administering the shot to anyone under 55. It has no plans to rescind it's overall approval of the vaccine at this time.

Multiple Charges Laid after Thefts in Tillsonburg
CASS Offering Unique Program to Students
PJHL Preview - Jan. 30th to Feb. 1st
Woodstock Bowler Heading to Special Olympics
Dog Bite Investigation in Tillsonburg
Interview with the Warden - January 29th, 2026
Trevor Birtch Trial Daily Recap - Case 2
11 People Charged in Massive Drug Bust
Another Cold Warning for Oxford County
Chilly Charlie Returns on Monday
Khanna Shines a Light on Oxford County Superstars
WFD Responds to Structure Fire
WPS Appoints New Deputy Chief
TMMC Woodstock Begins Production of Sixth Gen RAV4
Oxford OPP Briefs - January 28th, 2026
More Weather Alerts for Oxford County
Thrive Oxford Honoured at ROMA
Tip Tuesday with the Oxford OPP - January 2026
Members Needed for Tillsonburg Housing Advisory Committee
UPDATE: Ottawa Approves Plan to Move Marineland's Whales and Dolphins
Comments
Add a comment